Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2015.04.28
华英证券有限责任公司关于公司重大资产购置之一连督导意见
2015.04.28
华英证券有限责任公司关于公司2014年度召募资金存放与使用情形的核查意见
2015.04.28
2014年度监事会报告
2015.04.28
关于召开2014年度股东大会的通知通告
2015.04.28
第三届监事会第七次聚会决议通告
2015.04.28
2014年年度审计报告
2015.04.28
第三届董事会第十次聚会决议通告
2015.04.28
2014年度财务决算报告
2015.04.28
关于SPL Acquisition Corp.及其子公司盈利展望实现情形的专项审核报告
2015.04.28
关于美国全资子公司雇主养老金妄想投资的通告
第一页
上一页
98
99
100
101
102
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】